While viral infections may activate MC through binding of viral antigens to RIG-1 or TLR and C5a to C5aR/CD88, COVID-19 infection has previously not been related to significant MC activation symptoms in mastocytosis patients [33]—a finding which has been replicated in this study. This evidence concerns the gene PLAAT4 and mastocytosis.